Destum Partners provides innovative business solutions to companies within the life sciences industry. With over fifteen years of industry experience, Destum Partners strives to provide unmatched insight to companies at decision inflection points. Destum Partners provides its clients with a unique combination of services that begin with qualitative and quantitative analyses, followed by business recommendations based on those analyses, and finally the execution of those proposed recommendations. Destum Partners is a fully integrated consulting firm.


Mission Statement:
To be the leading provider of consulting and advisory services that allow clients to improve the quality of life of humanity.

Core Values:

Team Work: We understand that in order to accomplish great things, we must work efficiently internally, with our clients and with the industry.

Integrity: Our ability to succeed is based solely on the purity of our intentions. We are committed to always doing the right thing no matter the consequences.

Be the Client: We will treat our clients as we would expect to be treated, with respect and honesty.

Touch Humanity: Our motivation for working tirelessly for our clients is done with the end goal of improving disease diagnosis management and treatment.

Testimonials

"Our relationship with Gareth Lugg has been extremely rewarding not only were the analytics and strategic guidance provided by Gareth instrumental in Novalar Pharmaceuticals defining its licensing strategy his persistence commitment and enthusiasm for our project made him an highly valued and essential member of our Business Development team."

Donna Janson - President and CEO Novalar Pharmaceuticals.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - -

"The Valuation Analysis performed by Gareth Lugg provided us guidance on the key strategy to extract maximal value for our asset"

Peter Lens - FMR CBO Catchmabs B.V.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - -

"The financial analytics performed by Gareth Lugg was insightful and forced us to be more selective with our sources of expansion capital. My experience was very positive and I hope to work with Gareth and his team again in the future."

Dr. Yousef HajAhmad - President and CEO Norgen Biotek.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - -